Clinical trial to evaluate the effect of Madhumehavinashini Gutika and Jwarahara Kashaya on Blood sugar levels in adults with type 2 Diabetes Mellitus.

Randomized comparative clinical trial To evaluate the efficacy of Madhumehavinashini Gutika with and without Jwarahara Kashaya in the management of Madhumeha with special reference to Diabetes Mellitus Type II. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100117

Enrollment

Registered

2026-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between age group 30-65 years 2.Patient having signs and symptoms of Madhumeha 3.Diagnosed cases of Type 2 Diabetes Mellitus 4.Patient with FBS in range of 126-250mg/dl OR 5.PPBS-in range of 160-350mg/dl OR BOTH 6.Patients on Oral hypo-glycemic drugs for a duration less than or equal to 1 year with poor glycemic control.(as mentioned in above points) 7.Willingness to participate in the study and provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women 2.Patients having Type-1 Diabetes Mellitus. 3.FBS more than 250 mg/dl and PPBS more than 350 mg/dl. 4.Patients of Type-2 diabetes mellitus who are on insulin therapy and Drug induced diabetes mellitus. 5.Type-2 diabetes mellitus with complications and Madhumeha with Ashadhya upadrava 6.History of hypersensitivity or allergy to study drugs 7.Uncontrolled hypertension (systolic blood pressure more than 180 mmHg or diastolic blood pressure more than 100 mmHg) 8.Presence of any other serious medical condition that may interfere with study participation

Design outcomes

Primary

Measure	Time frame
-The primary outcome of the study will be the change in FBS/PPBS levels from baseline to the end of the treatment period.Timepoint: -Baseline to the end of the treatment period.	—

Secondary

Measure	Time frame
-Secondary outcomes will include changes in subjective parameters and incidence of adverse events.Timepoint: Baseline to the end of the treatment period.	—

Countries

India

Contacts

Public ContactDr Ajay Kumar Sahu Sir

National Institute of Ayurveda, Deemed to be university, Jaipur

drajaysahu@gmail.com9950708106

Outcome results